Guardion Health Sciences Reports First Quarter 2020 Financial Results and Provides Corporate Update
14 mai 2020 07h00 HE
|
Guardion Health Sciences, Inc.
— 40% increase in medical foods revenue in the first quarter compared to the same period last year — Launch of immuno-supportive/antioxidant complex, acuMMUNE™ — Growing portfolio of synergistic...
Lumega-Z® Demonstrates Superiority in a Head-to-Head Study Showing Better Bioavailability of Carotenoids and Restoring Macular Pigment Density
12 mai 2020 07h05 HE
|
Guardion Health Sciences, Inc.
-- First study to provide a head-to-head comparison of two commercially available supplements with regard to the changes in serum levels of carotenoids, visual function and macular pigment optical...
Guardion Health Sciences to Present at the April 2020 Virtual Investor Summit
15 avr. 2020 09h05 HE
|
Guardion Health Sciences, Inc.
– Presentation with live audio webcast on Wednesday, April 22 at 1:30 PM ET, immediately followed by an interactive Q&A session – San Diego, California, April 15, 2020 (GLOBE NEWSWIRE)...
Guardion Health Sciences Receives $3.5 Million from Exercise of Warrants
06 mars 2020 08h05 HE
|
Guardion Health Sciences, Inc.
San Diego, California, March 06, 2020 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (Nasdaq: GHSI), an ocular health sciences company that develops, formulates,...
Guardion® Appoints Experienced Executive to Lead Development and Expansion of Recently-Acquired NutriGuard Business Line
07 janv. 2020 11h02 HE
|
Guardion Health Sciences, Inc.
San Diego, California, Jan. 07, 2020 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (Nasdaq: GHSI), a leader in the field of ocular health technologies and...
Guardion Health Sciences, Inc. Reports Results for the Three and Nine Months Ended September 30, 2019
14 nov. 2019 07h00 HE
|
Guardion Health Sciences, Inc.
Results Highlighted by 33% Increase in Revenues for Guardion’s Flagship Medical Food Lumega-Z® San Diego, CA, Nov. 14, 2019 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the...
Guardion® Receives approval from USPTO for expanded claims for its Proprietary Medical Device, the MAPCAT SF
23 oct. 2019 07h00 HE
|
Guardion Health Sciences, Inc.
San Diego, California, Oct. 23, 2019 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (Nasdaq: GHSI) announced that it has received approval from the USPTO for...
Guardion Launches VectorVision CSV-2000 Standardized Contrast Sensitivity Test
03 sept. 2019 07h00 HE
|
Guardion Health Sciences, Inc.
New Generation of Vision Testing Technology to be Introduced at Vision Expo West San Diego, CA, Sept. 03, 2019 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the “Company”)...
Guardion Health Sciences Closes $5.8 Million Underwritten Public Offering
15 août 2019 16h05 HE
|
Guardion Health Sciences, Inc.
San Diego, CA , Aug. 15, 2019 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (Nasdaq: GHSI), today announced the closing of its previously announced underwritten...
Guardion Health Sciences Announces an Increase in the Pricing of its Previously Announced Underwritten Public Offering
15 août 2019 08h35 HE
|
Guardion Health Sciences, Inc.
San Diego, CA, Aug. 15, 2019 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (Nasdaq: GHSI), previously announced the pricing of an underwritten public offering of...